Med Check

May 2011 in “ Psychiatric News ”

Leslie Sinclair

TLDR Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

The document provided a regulatory update on the FDA's approval of Horizant for restless legs syndrome, highlighting its conversion to gabapentin and associated risks of suicidal thoughts. It also covered a legal case where Johnson & Johnson was found to have violated consumer protection laws with misleading claims about Risperdal. Industry briefs included Targacept's unsuccessful ADHD trial with TC-5619, a licensing agreement for lurasidone between DSP and Takeda, a recall of mislabeled citalopram and finasteride by Greenstone, and the launch of Reminyl for Alzheimer's in Japan. Additionally, Quanterix Corporation reported elevated Abeta42 levels in cardiac arrest patients, suggesting a link between hypoxia and Alzheimer's disease.

View this study on psychiatryonline.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Stopped fin for 26 days, did I lose any permanent gains?

in Finasteride 33 upvotes 3 days ago

The user stopped finasteride for 26 days and is concerned about losing hair regrowth. Another user suggests they will likely return to their pre-stop baseline but advises consulting a doctor.

community Starting finasteride before dermatologist (I’ll explain)

in Finasteride 215 upvotes 4 days ago

A 19-year-old male is experiencing hair loss and has been prescribed finasteride by a Telehealth company. He plans to start finasteride, improve his lifestyle, and take supplements like DIM and Zinc to manage potential side effects.

community When to switch from finasteride to dutasteride and how long to wait for dutasteride to build up

in Finasteride 135 upvotes 1 week ago

The user is considering switching from finasteride to dutasteride for hair loss treatment and is unsure when to stop finasteride. Dutasteride takes about 15 days to reach significant DHT suppression compared to finasteride.

community Experiencing Anxiety and Fatigue After 1 Week on Finasteride – Looking for Advice

in Finasteride 74 upvotes 1 week ago

The user experienced anxiety, dizziness, and fatigue after starting finasteride and is seeking advice on whether to continue, adjust the dose, or consult a doctor. They stopped taking finasteride and are unsure if it caused their symptoms.

community 18M, 8 Months on Minoxidil & Finasteride, Considering Dermaroller for Hairline Regrowth

in Finasteride 61 upvotes 3 weeks ago

The user is experiencing hair loss at Norwood 2.5 and is using minoxidil, finasteride, and vitamins, noticing minimal regrowth after 8 months. They are considering using a dermaroller but are unsure of its effectiveness.

community Concern About Misapplication of Finasteride/Minoxidil After 2 Years Use and Hairline Recession

in Finasteride 98 upvotes 3 weeks ago

The user experienced hairline recession despite using topical finasteride/minoxidil and is considering whether misapplication was the cause. They are exploring options after experiencing side effects from oral finasteride, including possibly returning to the topical formulation with adjusted application methods.

Similar Research

6 / 1000+ results

research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

1707 citations , December 2003 in “The New England Journal of Medicine”

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

1054 citations , February 1998 in “The New England Journal of Medicine”

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

research The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

1040 citations , October 1992 in “The New England Journal of Medicine”

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations

research Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations

823 citations , February 1998 in “Analytical Chemistry”

Method detects finasteride in plasma at very low concentrations.

research The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

728 citations , August 1996 in “The New England Journal of Medicine”

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations , October 1998 in “Journal of The American Academy of Dermatology”

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.